Results 191 to 200 of about 340,819 (312)

Craniofacial Resection for Advanced Cutaneous Squamous Cell Carcinoma: Results From the 2nd International Collaborative Case‐Series

Head &Neck, EarlyView.
ABSTRACT Background Robust outcome data for anterior skull base cutaneous squamous cell carcinoma (cSCC) are limited, particularly as emerging therapies reshape management. We evaluated survival and prognostic factors following craniofacial resection. Methods Retrospective multi‐institutional case‐series (1995–2015) of patients who underwent skull base
Michael J. C. Schachtel, Benedict J. Panizza, James J. Bowman, Catherine Barnett, Cristina Valero, Ian Ganly, Snehal G. Patel, Helena Levyn, Dauren Adilbay, Alana Eagan, Marc A. Cohen, Lillian A. Boe, Junting Zheng, Mithat Gonen, Prathamesh Pai, Paolo Castelnuovo, Fang Ju Gao, Cesare Piazza, Piero Nicolai, Luiz P. Kowalski, Ronaldo N. Toledo, Claudio Cernea, Sergio Goncalves, Dan M. Fliss, John R. de Almeida, Ian Witterick, Philippe Herman, Walter Fontanella, Gregorio Sanchez Aniceto, Alvaro Rivero Calle, Sefik Hosal, Serdar Ozer, Subramania Iyer, Richard J. Harvey, C. Rene Leemans, Jan‐Jaap Hendrickx, Marcelo Figari, Luis Boccalatte, Ken Ichi Nibu, Peter Clarke, Catherine Rennie, Yiming Zhu, Rodney J. Schlosser, Fernando L. Dias, Zoukaa Sargi, Shahzada Ahmed, Wojciech Golusinski, Se Heon Kim, Shirley Y. Su, Shaan M. Raza, Franco DeMonte, Ehab Hanna, Jatin P. Shah   +52 more
wiley   +1 more source

Bone‐Anchored Implant Survival in Oncologic Facial Prosthetic Rehabilitation

Head &Neck, EarlyView.
ABSTRACT Background Published survival rates for bone‐anchored craniofacial implants exceed 85%, but derive largely from mixed populations. Whether these apply to head and neck oncologic surgery remains uncertain. Methods Retrospective survival analysis of implants placed for prosthetic rehabilitation following extirpative surgery at a UK center (2005 ...
Oliver Blanshard, Sarah Jones, Peter M. Clarke, Jonathan M. Bernstein   +3 more
wiley   +1 more source

Proximal Humerus Ewing Sarcoma: Technical Challenges and Strategies for Bone Defect Reconstruction. [PDF]

J Orthop Case Rep
Mhenni RB, Chtai S, Khlifa MA, Siala A, Maitigue MB, Bouattour K.   +5 more
europepmc   +1 more source

Corrigendum to "Biomarkers of prognosis and pazopanib response in soft tissue sarcoma: An exploratory analysis". [PDF]

Ther Adv Med Oncol
europepmc   +1 more source

Understanding Diagnostic Challenges in Ewing Sarcoma - A Report of Two Cases. [PDF]

J Orthop Case Rep
Prabhakar R, Dhariwal HV, Sivaprasad KM, Chandar RP.   +3 more
europepmc   +1 more source

PROGNOSTIC FACTORS IN THE SURGICAL TREATMENT OF RECURRENT RETROPERITONEAL SARCOMAS: RESULTS OF A SINGLE-CENTER STUDY

reservedIntroduzione. La recidiva locoregionale di sarcoma retroperitoneale rappresenta da sempre una sfida terapeutica. Sebbene la chirurgia estesa sia riconosciuta come trattamento standard del sarcoma retroperitoneale primario, il corretto trattamento
SALIMIAN, NICK
core  

Exploring Neutrophil Extracellular Traps in Canine Soft Tissue Sarcomas: A Preliminary Study With Translational Insights. [PDF]

Vet Med Sci
Yildirim B, Ipek V.
europepmc   +1 more source

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis

Ibrain, Volume 11, Issue 1, Page 74-83, Spring 2025.
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley   +1 more source

Liposomal doxorubicin in the treatment of AIDS-associated Kaposi's sarcoma [PDF]

, 1994
Bogner, Johannes R., Goebel, Frank-Detlef, Zietz, C., Stürzl, M., Hofschneider, P. H., Gillitzer, R., Eisenburg, B.   +6 more
core   +1 more source

Not all NTRK fusions in mesenchymal neoplasia are driver events: implications on classification and targeted therapy. [PDF]

J Pathol Clin Res
Yakoub MA, Sukhadia P, Saoud C, Hameed M, Antonescu CR.   +4 more
europepmc   +1 more source